190 related articles for article (PubMed ID: 23092529)
1. A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children.
Williams L; Malhotra Y; Murante B; Laverty S; Cook S; Topa D; Hardy D; Wang H; Gigliotti F
J Pediatr; 2013 Apr; 162(4):857-61. PubMed ID: 23092529
[TBL] [Abstract][Full Text] [Related]
2. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.
Granet DB; Dorfman M; Stroman D; Cockrum P
J Pediatr Ophthalmol Strabismus; 2008; 45(6):340-9. PubMed ID: 19043945
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis.
Wagner RS
J Pediatr Ophthalmol Strabismus; 2008; 45(6):330. PubMed ID: 19043943
[No Abstract] [Full Text] [Related]
5. Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.
Lichtenstein SJ; De Leon L; Heller W; Marshall B; Cupp G; Foster K; McLean C; Levy S; Stroman DW
J Pediatr Ophthalmol Strabismus; 2012; 49(2):88-97. PubMed ID: 22074357
[TBL] [Abstract][Full Text] [Related]
6. Results of a survey of children with acute bacterial conjunctivitis treated with trimethoprim-polymyxin B ophthalmic solution.
Wagner RS
Clin Ther; 1995; 17(5):875-81. PubMed ID: 8595639
[TBL] [Abstract][Full Text] [Related]
7. Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.
Tauber S; Cupp G; Garber R; Bartell J; Vohra F; Stroman D
Adv Ther; 2011 Jul; 28(7):566-74. PubMed ID: 21681652
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.
Nozik RA; Smolin G; Knowlton G; Austin R
Ann Ophthalmol; 1985 Dec; 17(12):746-8. PubMed ID: 2418736
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
Comstock TL; Paterno MR; Usner DW; Pichichero ME
Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
[TBL] [Abstract][Full Text] [Related]
11. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
12. Controlling contagious bacterial conjunctivitis.
Lichtenstein SJ; Dorfman M; Kennedy R; Stroman D
J Pediatr Ophthalmol Strabismus; 2006; 43(1):19-26. PubMed ID: 16491721
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis.
van Rensburg SF; Gibson JR; Harvey SG; Burke CA
Pharmatherapeutica; 1982; 3(4):274-7. PubMed ID: 6292957
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group.
J Antimicrob Chemother; 1989 Feb; 23(2):261-6. PubMed ID: 2540136
[TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.
Keating GM
Drugs; 2011 Jan; 71(1):89-99. PubMed ID: 21175242
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three topical antimicrobials for acute bacterial conjunctivitis.
Lohr JA; Austin RD; Grossman M; Hayden GF; Knowlton GM; Dudley SM
Pediatr Infect Dis J; 1988 Sep; 7(9):626-9. PubMed ID: 2845348
[TBL] [Abstract][Full Text] [Related]
17. Short term oral cefixime therapy for treatment of bacterial conjunctivitis.
Wald ER; Greenberg D; Hoberman A
Pediatr Infect Dis J; 2001 Nov; 20(11):1039-42. PubMed ID: 11734708
[TBL] [Abstract][Full Text] [Related]
18. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
20. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
